Search Results - "Castaldi MP"

The RNA promoter for pathogenic orthoflaviviruses replication is universal and serves as target for viral inhibition.

Authors: Oviedo-Rouco, Santiago Bertoni, Lautaro Mikkelsen, Evelyn et al.

Source: PLoS Pathogens. 5/18/2026, Vol. 22 Issue 5, p1-29. 29p.

A comprehensive review on nucleoside mimicking fluorescent probes with photophysical properties and application.

Authors: Bhatia, Simran Kaur Manna, Emili Kuchlyan, Jagannath

Source: Discover Chemistry. 7/17/2026, Vol. 3 Issue 1, p1-28. 28p.

Pharmacological significance of palbociclib and its derivatives in cancer treatment and prevention: an update.

Authors: Shagufta Ahmad, Irshad Bazbouz, Laila Zeyad et al.

Source: Medicinal Chemistry Research. Jun2025, Vol. 34 Issue 6, p1237-1252. 16p.

The rise of targeting chimeras (TACs): next-generation medicines that preempt cellular events.

Authors: Hollingsworth, Scott Johnson, Scott Khakbaz, Pouyan et al.

Source: Medicinal Chemistry Research. Jul2023, Vol. 32 Issue 7, p1294-1314. 21p.

Proteolysis-targeting chimera (PROTAC) in cancer: design principles and applications on "undruggable" targets.

Authors: Lu X Qin J Dong S et al.

Source: Biomarker research [Biomark Res] 2026 May 21; Vol. 14 (1). Date of Electronic Publication: 2026 May 21.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE

Ab initio calculation of the evolution of [SiN4‐nOn] tetrahedron during β‐Si3N4(0001) surface oxidation.

Authors: Cai, Jianpeng Hou, Xinmei Fang, Zhi et al.

Source: Journal of the American Ceramic Society; Apr2020, Vol. 103 Issue 4, p2808-2816, 9p, 3 Diagrams, 2 Graphs

Protacs in cancer therapy: mechanisms, design, clinical trials, and future directions.

Authors: Vikal A Maurya R Patel BB et al.

Source: Drug delivery and translational research [Drug Deliv Transl Res] 2025 Jun; Vol. 15 (6), pp. 1801-1827. Date of Electronic Publication: 2024 Nov 29.

Publication Type: Journal Article; Review

Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101540061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2190-3948 (Electronic) Linking ISSN: 2190393X NLM ISO Abbreviation: Drug Deliv Transl Res Subsets: MEDLINE

B-cell lymphoma 6 in breast cancer: molecular mechanisms and clinical significance.

Authors: Louwen, Frank Ritter, Andreas Kreis, Nina-Naomi et al.

Source: Critical Reviews in Biochemistry & Molecular Biology. Feb-Jun2025, Vol. 60 Issue 1-3, p80-106. 27p.

Reimagining GSK-3β Therapeutics in Alzheimer's Disease: From Inhibition to Activity Normalization and Targeted Degradation.

Authors: Manni E Al-Kuraishy HM Eisawy R et al.

Source: Journal of molecular neuroscience : MN [J Mol Neurosci] 2026 Apr 24; Vol. 76 (2). Date of Electronic Publication: 2026 Apr 24.

Publication Type: Journal Article; Review

Journal Info: Publisher: Humana Press Country of Publication: United States NLM ID: 9002991 Publication Model: Electronic Cited Medium: Internet ISSN: 1559-1166 (Electronic) Linking ISSN: 08958696 NLM ISO Abbreviation: J Mol Neurosci Subsets: MEDLINE

The emerging role of proteolysis targeting chimeras (PROTACs) in the treatment of Alzheimer's disease.

Authors: George, Namy Akhtar, Md. Jawaid Balushi, Khalid Al et al.

Source: Medicinal Chemistry Research. Apr2023, Vol. 32 Issue 4, p601-616. 16p.

New-generation advanced PROTACs as potential therapeutic agents in cancer therapy.

Authors: Wang, Chao Zhang, Yujing Chen, Wujun et al.

Source: Molecular Cancer. 5/21/2024, Vol. 23 Issue 1, p1-41. 41p.

Polycomb repressive complex 2 and its core component EZH2: potential targeted therapeutic strategies for head and neck squamous cell carcinoma.

Authors: Cheng, Yuxi Song, Zhengzheng Fang, Xiaodan et al.

Source: Clinical Epigenetics. 4/10/2024, Vol. 16 Issue 1, p1-16. 16p.

Antibody designing against IIIabc junction (JIIIabc) of HCV IRES through affinity maturation; RNA-Antibody docking and interaction analysis.

Authors: Ejaz, Saima Paracha, Rehan Zafar Ejaz, Sadaf et al.

Source: PLoS ONE. 9/8/2023, Vol. 18 Issue 9, p1-19. 19p.

Ab initio calculation of the evolution of [SiN4‐nOn] tetrahedron during β‐Si3N4(0001) surface oxidation.

Authors: Cai, Jianpeng Hou, Xinmei Fang, Zhi et al.

Source: Journal of the American Ceramic Society. Apr2020, Vol. 103 Issue 4, p2808-2816. 9p. 3 Diagrams, 2 Graphs.

Molecular glues: enhanced protein-protein interactions and cell proteome editing.

Authors: Weagel, Evita G. Foulks, Jason M. Siddiqui, Adam et al.

Source: Medicinal Chemistry Research. Jul2022, Vol. 31 Issue 7, p1068-1087. 20p.

Protein degradation technology: a strategic paradigm shift in drug discovery.

Authors: Li, Haobin Dong, Jinyun Cai, Maohua et al.

Source: Journal of Hematology & Oncology. 9/6/2021, Vol. 14 Issue 1, p1-23. 23p.

Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.

Authors: Halilovic M Abdelsalam M Zabkiewicz J et al.

Source: Leukemia [Leukemia] 2024 Dec; Vol. 38 (12), pp. 2561-2572. Date of Electronic Publication: 2024 Sep 17.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE

Proteolysis targeting chimeras (PROTACs) are emerging therapeutics for hematologic malignancies.

Authors: He, Yonghan Khan, Sajid Huo, Zhiguang et al.

Source: Journal of Hematology & Oncology. 7/27/2020, Vol. 13 Issue 1, p1-24. 24p.

Hepatitis C viral protein translation: mechanisms and implications in developing antivirals.

Authors: Hoffman, Brett Liu, Qiang

Source: Liver International. Nov2011, Vol. 31 Issue 10, p1449-1467. 19p. 1 Diagram, 1 Chart.

Identification of the IFITM3 gene as an inhibitor of hepatitis C viral translation in a stable STAT1 cell line.

Authors: Yao, L. Dong, H. Zhu, H. et al.

Source: Journal of Viral Hepatitis. Oct2011, Vol. 18 Issue 10, pe523-e529. 7p. 2 Black and White Photographs, 3 Graphs.